ASSET PURCHASE AGREEMENT BY AND BETWEEN Elite Pharmaceuticals, Inc. AND NOSTRUM LABORATORIES INC. DATED AS OF November 13, 2019 This document is not intended to create, nor will it be deemed to create, a legally binding or enforceable offer or...Asset Purchase Agreement • February 10th, 2020 • Elite Pharmaceuticals Inc /Nv/ • Pharmaceutical preparations • New York
Contract Type FiledFebruary 10th, 2020 Company Industry JurisdictionThis Asset Purchase Agreement (this “Agreement”), dated as of November 13, 2019, is entered into by and between Elite Pharmaceuticals, Inc., a Nevada corporation (“Seller”), and Nostrum Laboratories Inc., a New Jersey, USA corporation (“Buyer”). Seller and Buyer shall be referred to herein from time to time collectively as the “Parties” and individually as a “Party”. Capitalized words have the definitions set forth in Annex A.
ASSET PURCHASE AGREEMENTAsset Purchase Agreement • February 10th, 2020 • Elite Pharmaceuticals Inc /Nv/ • Pharmaceutical preparations • New York
Contract Type FiledFebruary 10th, 2020 Company Industry JurisdictionThis Asset Purchase Agreement (this “Agreement”), dated as of December 16, 2019, is entered into by and between Elite Pharmaceuticals, Inc., a Nevada corporation (“Seller”), and Nostrum Laboratories Inc., a New Jersey, USA corporation (“Buyer”). Seller and Buyer shall be referred to herein from time to time collectively as the “Parties” and individually as a “Party”. Capitalized words have the definitions set forth in Annex A.